Zen Peptides Retatrutide
As of 9 Aug 2026, Finnrick has published 10 independent lab tests of Retatrutide from Zen Peptides: 6 passed and 4 failed under the default public standard, Purity Focus (HPLC purity at least 99.5%, fill within ±35% of the label claim). The latest test is dated 20 Jul 2026. The current Finnrick rating for Zen Peptides Retatrutide is 71%.
Finnrick ratings are recency-weighted pass percentages: newer tests count more, and vendors with thin test histories are pulled toward the peer baseline for that peptide, so a single result cannot look too certain. Samples are analyzed by independent partner laboratories and the results are published by Finnrick Analytics, which does not sell peptides and does not accept payment to alter ratings. Corrections to published data are recorded at finnrick.com/corrections.
Interactive charts, prices, and test history for this page load with JavaScript; the facts above are from Finnrick's published test database.
| Date | Result | Certificate |
|---|---|---|
| 20 Jul 2026 | Fail | Certificate degzrry |
| 3 Mar 2026 | Pass | Certificate ux7242t |
| 3 Mar 2026 | Pass | Certificate k738s4y |
| 10 Feb 2026 | Pass | Certificate mm7bdk9 |
| 7 Jan 2026 | Pass | Certificate z3w4hc7 |
| 1 Jan 2026 | Pass | Certificate 8832ygt |
| 10 Dec 2025 | Fail | Certificate rmd5cfv |
| 17 Nov 2025 | Fail | Certificate py3qn9c |
| 17 Nov 2025 | Pass | Certificate 5rx8xnp |
| 23 Oct 2025 | Fail | Certificate s36d2xj |